| LIST OF ANTIBODIES: ORDER INFORMATION, SHIPPING AND STORAGE |
| order # |
product |
reactive* |
applic.* |
description |
amount |
| Signal transduction |
| 2499PR |
Anti-CIKS (CT) |
h. |
WB |
Activator of IKK, ATF and AP-1 |
100 µg |
| 2501PR |
Anti-CIKS (NT) |
h. |
WB |
Activator of IKK, ATF and AP-1 |
100 µg |
| 24259SB |
Anti-hPIP1 |
h. |
WB,IHC |
Human PAK-interacting protein |
100 µg |
| 24164SB |
Anti-IKAP (CT) |
h. |
WB,IHC |
Inflammatory cytokine signaling |
100 µg |
| 24163SB |
Anti-IKAP (NT) |
h. |
WB,IHC |
Inflammatory cytokine signaling |
100 µg |
| 2025PR |
Anti-IKKa (C1) |
h. |
WB, IHC |
IkB serine protein kinase alpha |
100 µg |
| 2115PR |
Anti-IKKa (C2) |
h. |
WB |
IkB serine protein kinase alpha |
100 µg |
| 2117PR |
Anti-IKKa (C3) |
h. |
WB |
IkB serine protein kinase alpha |
100 µg |
| 2121PR |
Anti-IKKb (C3) |
h. |
WB |
IkB serine protein kinase beta |
100 µg |
| 2329PR |
Anti-IKKe/IKK-I (CT) |
h. |
WB |
IkB kinase epsilon |
100 µg |
| 24162SB |
Anti-IKKg (CT) |
h. |
WB,IHC |
IkB kinase gamma |
100 µg |
| 24161SB |
Anti-IKKg (NT)** |
h. |
WB,IHC |
IkB kinase gamma |
100 µg |
| 2335PR |
Anti-IKKg/NEMO (NT)** |
h. m. r. |
WB |
IkB kinase gamma |
100 µg |
| 2131PR |
Anti-IL-1RAcP (C1) |
h. |
WB |
IL-1 receptor accessory protein |
100 µg |
| 2129PR |
Anti-IL-1RAcP (C2) |
h. |
WB |
IL-1 receptor accessory protein |
100 µg |
| 1007PR |
Anti-IRAK (CT) |
h. |
WB, IP |
IL-1 receptor associated kinase |
100 µg |
| 2123PR |
Anti-IRAK2 (C2) |
h. |
WB |
IL-1R receptor associated kinase |
100 µg |
| 2213PR |
Anti-IRAK-2 (CT) |
h. |
WB |
IL-1R receptor associated kinase |
100 µg |
| 3125PR |
Anti-IRAK-4 |
h. |
WB |
A member in IRAK/Pelle family |
100 µg |
| 2355PR |
Anti-IRAK-M |
h. m. r. |
WB |
Novel IL-1R associated kinase |
100 µg |
| 24229SB |
Anti-Kidins220** |
h. |
WB,IHC |
Kinase D-interacting substrate |
100 µg |
| 24251SB |
Anti-Kidins220** |
h. |
WB,IHC |
Kinase D-interacting substrate |
100 µg |
| 24332SB |
Anti-Kos1 |
m. |
WB, IHC |
Nonreceptor protein tyrosine kinase |
100 µg |
| 1150PR |
Anti-MADD (CT) |
h. |
WB |
MAPK pathway activator |
100 µg |
| 2127PR |
Anti-MyD88 (CT) |
h. |
WB |
Adapter in IL-1 and LPS signaling |
100 µg |
| 2125PR |
Anti-MyD88 (IN) |
h. m. |
WB |
Adapter in IL-1 and LPS signaling |
100 µg |
| 2351PR |
Anti-NAK/TBK1 (CT) |
h. m. |
WB |
NF-kappaB activating kinase |
100 µg |
| 1129PR |
Anti-NIK (CT) |
h. |
WB |
NFkB inducing kinase |
100 µg |
| 1107PR |
Anti-p62DOK (CT) |
h. |
WB |
Tyrosine kinase substrate |
100 µg |
| 24314SB |
Anti-PAPK |
m. |
WB, IHC |
Novel polyploidy-associated protein kinase |
100 µg |
| 24222SB |
Anti-PKD2 |
h. |
WB,IHC |
Protein kinase D2, ser/thr kinase |
100 µg |
| 24287SB |
Anti-SERPINB10 |
h. |
WB,IHC |
Inh. of trypsin-like ser-proteases |
100 µg |
| 24285SB |
Anti-SERPINB12 |
h. |
WB,IHC |
Inh. of trypsin-like ser-proteases |
100 µl |
| 24286SB |
Anti-SERPINB13 |
h. |
WB,IHC |
Inh. of trypsin-like ser-proteases |
100 µg |
| 1125PR |
Anti-SIRPa (CT) |
h. |
WB |
Tyrosine kinase substrate |
100 µg |
| 1021PR |
Anti-STAT1a (CT) |
h. |
WB, IP |
JAK activated transcription factor |
100 µg |
| 3385PR |
Anti-TAK1 (NT) (MAP3K7) |
h. m. r. |
WB, IP |
TGF-beta activated protein kinase |
100 µg |
| 3129PR |
Anti-TRAF6(CT) |
h. m. r. |
WB |
TNF receptor associated factor |
100 µg |
| order # |
product |
reactive* |
applic.* |
description |
amount |
| Nuclear proteins and hormone receptors |
| 24139SB |
Anti-Alien |
h. |
WB, IHC |
Interacting with thyroid hormone receptor |
100 µg |
| 24178SB |
Anti-hp8/com1 (CT) |
h. |
WB, IHC |
Nuclear protein with strong mitogenic activity |
100 µg |
| 24177SB |
Anti-hp8/com1 (NT) |
h. |
WB, IHC |
Nuclear protein with strong mitogenic activity |
100 µg |
| 24228SB |
Anti-RanBP17 |
h. |
WB, IHC |
RanGTP-binding protein, nuclear receptor |
100 µg |
| HIV coreceptors and chemokine receptors |
| 1170PR |
Anti-Bonzo (CT) |
h. |
WB |
HIV coreceptor |
100 µg |
| 2209PR |
Anti-Bonzo (NT2) |
h. |
WB |
HIV coreceptor |
100 µg |
| 1112PR |
Anti-CCR5 (NT) |
h. |
WB |
HIV and chemokine receptor |
100 µg |
| 2097PR |
Anti-CCR8 (EL) |
h. |
WB |
HIV and chemokine receptor |
100 µg |
| 2201PR |
Anti-CX3CR1 (EL) |
h. |
WB |
HIV and chemokine receptor |
100 µg |
| 2093PR |
Anti-CX3CR1 (NT) |
h. |
WB |
HIV and chemokine receptor |
100 µg |
| 1012PR |
Anti-CXCR4 (EL) |
h. |
WB |
HIV and chemokine receptor |
100 µg |
| 1009PR |
Anti-CXCR4 (NT) |
h. |
WB, IP, IHC |
HIV and chemokine receptor |
100 µg |
| 2347PR |
Anti-DC-SIGN (CT) |
h. |
WB |
dendritic HIV-binding protein |
100 µg |
| 2349PR |
Anti-DC-SIGN (ED) |
h. |
WB |
dendritic HIV-binding protein |
100 µg |
| 1123PR |
Anti-Eotaxin (CT) |
h. |
WB |
CCR3 ligand |
100 µg |
| 2101PR |
Anti-GPR15/BOB (NT) |
h. |
WB |
HIV coreceptor |
100 µg |
shipped on blue ice; storage: see respective data sheet
antibody source: rabbit
Abbreviations:
* h.: human, m.: mouse, r. : rat, tested in: WB: Western blot, IP: immunoprecipitation, IHC: immunohistochemistry, AI: apoptose induction, I: inhibition, Inh.: Inhibitor CT: C-terminus; C1, C2, C3: C-termini 1, 2 and 3, NT: N-terminus, IN: intermediate domain,
ED: extracellular domain, ID: intracellular domain.
Control lysates of cell lines and tissues and blocking peptides are available for testing upon request.
**: different antigen-targets
|